| Final fixing |
Security/ Underlying |
Product type | Redemption | Curr. | Bid/ Ask |
TS |
|---|---|---|---|---|---|---|
| 07.01.26 |
140250428
Tesla Motors A |
Barrier reverse convertible | 14.01.2026 | qCHF |
103.54% 0.00% | |
| 07.01.26 |
140250436
Basket |
Barrier reverse convertible | 14.01.2026 | CHF |
100.99% 0.00% | |
| 07.01.26 |
140250435
Cie Fin Richemont N |
Barrier reverse convertible | 14.01.2026 | CHF |
105.29% 0.00% | |
| 07.01.26 |
140250439
Novartis N Roche GS |
Barrier reverse convertible | 14.01.2026 | CHF |
102.39% 0.00% | |
| 07.01.26 |
140250447
Alcon N Sonova Hldg N Straumann Hldg N |
Barrier reverse convertible | 14.01.2026 | CHF |
78.89% 0.00% | |
| 07.01.26 |
140250450
Nestlé N Novartis N Swiss Re N |
Barrier reverse convertible | 14.01.2026 | CHF |
102.33% 0.00% | |
| 07.01.26 |
140250452
Lonza Grp N Novartis N Roche GS |
Barrier reverse convertible | 14.01.2026 | CHF |
102.23% 0.00% | |
| 07.01.26 |
140250453
Sonova Hldg N Alcon N Bachem Holding |
Barrier reverse convertible | 14.01.2026 | CHF |
102.23% 0.00% | |
| 07.01.26 |
140250462
ABB N Cie Fin Richemont N Roche GS |
Barrier reverse convertible | 14.01.2026 | CHF |
104.77% 0.00% | |
| 07.01.26 |
140250464
Givaudan N Nestlé N UBS Group AG |
Barrier reverse convertible | 14.01.2026 | CHF |
102.23% 0.00% |
| ZKB Reverse Convertible auf Novo Nordisk A/S 140250665 / CH1402506658 |
| ZKB Barrier Reverse Convertible on worst of Tecan Group AG/Ypsomed Holding AG/BACHEM HOLDING AG 140251602 / CH1402516020 |
| ZKB EQ Discount-Zertifikat auf Rheinmetall AG 144652793 / CH1446527934 |
| 10.4278% p.a. ZKB Barrier Reverse Convertible, 28.12.2026 auf AMS SE 130397952 / CH1303979525 |
| ZKB Barrier Reverse Convertible on worst of BACHEM HOLDING AG/Tecan Group AG/TEMENOS AG/VAT Group AG 142529512 / CH1425295123 |